Last Price$1.49Cboe Previous Close - Real-Time Last Sale as of 3:59PM ET 11/15/19
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$1.48 (100)
Ask (Size)$1.50 (3,380)
Day Low / HighN/A - N/A

Insider Trends: Insider Purchase Adds to OPKO Health Positive Trend

7:15AM ET 7/17/2019 MT Newswires
Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, executed a purchase for 50,000 shares of OPKO Health (OPK) on Jul 16, 2019, for $105,981. Following the Form 4 filing with the SEC, Dr Frost has control over 217,521,633 shares of company stock of which 3,068,951 shares are held directly and 214,452,682 are controlled indirectly. These holdings have an approximate market value of $456.8 million as of the prior-day closing price.

During the most recent 90-day period, previous to the date of this filing, there have been 35 insider transactions from the activities of 7 different insiders all of which have been purchases and resulted in the acquisition of 4,435,250 company shares. In the preceding 90-day window of time, there were 18 transactions from 2 insiders that resulted in the net acquisition of 897,232 shares.

This is less than the average level of insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Within the peer group activity averaged 36.7 transactions per company, and disposition of 6,750 shares on average.

SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119042302/xslF345X03/doc4.xml